Vinorelbine, Concentrate
Generic name: vinorelbine tartrate
Dosage form: injection, solution, concentrate
Drug class:Mitotic inhibitors
Medically reviewed by Drugs.com. Last updated on Aug 23, 2021.
On This Page
- Boxed Warning
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Vinorelbine, Concentrate
Vinorelbine injection USP is indicated:
- •
- In combination with cisplatin for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
- •
- As a single agent, for the treatment of patients with metastatic NSCLC
Vinorelbine, Concentrate Dosage and Administration
Recommended Dose
In Combination with Cisplatin 100 mg/m2
- •
- The recommended dose of vinorelbine injection is 25 mg/m2 administered as an intravenous injection or infusion over 6 to 10 minutes on days 1, 8, 15 and 21 of a 28 day cycle in combination with cisplatin 100 mg/m2 on day 1 only of each 28 day cycle.
In Combination with Cisplatin 120 mg/m2
- •
- The recommended dose of vinorelbine injec...
